- Home
- INDI vs EBS Comparison
INDI vs EBS Comparison
Compare INDI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDI
- EBS
- Stock Information
- Founded
- INDI 2007
- EBS 1998
- Country
- INDI United States
- EBS United States
- Employees
- INDI N/A
- EBS N/A
- Industry
- INDI Semiconductors
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- INDI Technology
- EBS Health Care
- Exchange
- INDI Nasdaq
- EBS Nasdaq
- Market Cap
- INDI 381.6M
- EBS 393.9M
- IPO Year
- INDI N/A
- EBS 2006
- Fundamental
- Price
- INDI $1.91
- EBS $4.62
- Analyst Decision
- INDI Strong Buy
- EBS Strong Buy
- Analyst Count
- INDI 6
- EBS 3
- Target Price
- INDI $7.50
- EBS $14.33
- AVG Volume (30 Days)
- INDI 4.3M
- EBS 1.3M
- Earning Date
- INDI 05-12-2025
- EBS 04-30-2025
- Dividend Yield
- INDI N/A
- EBS N/A
- EPS Growth
- INDI N/A
- EBS N/A
- EPS
- INDI N/A
- EBS N/A
- Revenue
- INDI $216,682,000.00
- EBS $1,043,600,000.00
- Revenue This Year
- INDI $25.74
- EBS N/A
- Revenue Next Year
- INDI $48.74
- EBS $19.88
- P/E Ratio
- INDI N/A
- EBS N/A
- Revenue Growth
- INDI N/A
- EBS N/A
- 52 Week Low
- INDI $1.53
- EBS $1.82
- 52 Week High
- INDI $7.82
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- INDI 41.79
- EBS 39.12
- Support Level
- INDI $1.78
- EBS $4.13
- Resistance Level
- INDI $2.16
- EBS $4.79
- Average True Range (ATR)
- INDI 0.23
- EBS 0.44
- MACD
- INDI 0.05
- EBS 0.11
- Stochastic Oscillator
- INDI 60.61
- EBS 41.67
About INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for advanced Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.